Narrow search
Showing 1 - 4 of 4
Cover Image
Response to Baker and Fugh-Berman's critique of my paper, "Why has longevity increased more in some states than in others?"
Lichtenberg, Frank R. - 2009
study was subject to a number of major methodological flaws. Many of their claims pertain to the role of infant mortality …. I show that infant mortality was not an important determinant of the growth in U.S. life expectancy during the period … that I studied, and that my estimates are completely insensitive to the inclusion or exclusion of infant mortality …
Persistent link: https://www.econbiz.de/10003861794
Cover Image
Sources of US longevity increase, 1960 - 1997
Lichtenberg, Frank R. - 2000
Between 1960 and 1997, life expectancy at birth of Americans increased approximately 10% G from 69.7 to 76.5 years G and it has been estimated that the value of life extension during this period nearly equaled the gains in tangible consumption. While life expectancy has tended to increase, there...
Persistent link: https://www.econbiz.de/10011397757
Cover Image
The impact of recent chemotherapy innovation on the longevity of Myeloma patients : U.S. and international evidence
Lichtenberg, Frank R.; Hostenkamp, Gisela - 2013
myeloma mortality rate using longitudinal country-level data on 26 countries during the period 2005-2009. Countries that had … larger increases in the number of chemotherapy regimens had larger subsequent declines in myeloma mortality rates …, controlling for other factors. The estimates imply that chemotherapy innovation reduced the age-adjusted myeloma cancer mortality …
Persistent link: https://www.econbiz.de/10010223067
Cover Image
How cost effective are new cancer drugs in the U.S.?
Lichtenberg, Frank R. - 2017
mortality from the cancers that had larger increases in the number of drugs ever approved, controlling for the change in cancer …
Persistent link: https://www.econbiz.de/10011735934